Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole for Depression in Parkinson's Disease
NCT00297778Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 4 trial of pramipexole in major depressive disorder (MDD), sponsored by Boehringer Ingelheim. Started Mar 2006; status: completed.
02
Drugs
pramipexole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00297778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00297778.